Terms: = Bone cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546 AND Prognosis
4 results:
1. Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Naglieri E; Niccoli Asabella A; Nappi AG; Carella C; Ferrari C; Rubini G
Medicine (Baltimore); 2019 Dec; 98(50):e18093. PubMed ID: 31852068
[TBL] [Abstract] [Full Text] [Related]
2. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
[TBL] [Abstract] [Full Text] [Related]
3. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathologic analysis of papillary renal cell carcinoma].
Zhang W; Li YJ
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):354-8. PubMed ID: 20723433
[TBL] [Abstract] [Full Text] [Related]
